Omeros Announces Positive Phase 2 Results For Its OMS721 Trial
August 18, 2015 at 20:27 PM EDT
Shares of Omeros closed the day up 72% after announcing positive phase 2 results for its treatment of thrombotic microangiopathies.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |